PR Newswire SAN DIEGO, May 20, 2013 /PRNewswire/ --TRACON Pharmaceuticals, a biopharmaceutical company that develops targeted therapies for... ...
http://www.asianhhm.com/news/news_archives.asp?NewsID=45663&title=TRACON-Pharmaceuticals-Announces-TRC105-Clinical-Trials-Abstract-Presentations-at-2013-ASCO-Annual-MeetingData on investigational compounds and an approved product will be presented PR Newswire RIDGEFIELD, Conn., May 17, 2013 /PRNewswire/ --Boehringer... ...
http://www.asianhhm.com/news/news_archives.asp?NewsID=45561&title=Boehringer-Ingelheim-to-Present-17-Abstracts-at-the-Annual-American-Thoracic-Society-International-Conference/PRNewswire/ --Ambit Biosciences Corporation today announced the pricing of its initial public offering of 8,125,000 shares of its common stock at... ...
http://www.asianhhm.com/news/news_archives.asp?NewsID=45437/PRNewswire/ --DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar Pharma") is pleased to provide the following update from President & CEO, Mr.... ...
http://www.asianhhm.com/news/news_archives.asp?NewsID=45447/PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced that data related to three Janssen Oncology compounds have been selected... ...
http://www.asianhhm.com/news/news_archives.asp?NewsID=45390
0 Followers
0 Followers
0 Followers
0 Followers
0 Followers